Market Overview:
The global general influenza diagnostics market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of influenza, rising demand for point-of-care (POC) tests, and technological advancements in diagnostic methods. Based on type, the global general influenza diagnostics market is segmented into rapid immunoassays (RIDTs), viral culture, direct fluorescent antibody (DFA), and serological assays. The RIDT segment is expected to account for the largest share of the global general influenza diagnostics market in 2018. This segment is projected to grow at a CAGR of 7% during the forecast period from 2018 to 2030. The large share of this segment can be attributed to its growing popularity among healthcare professionals owing to its ease of use and fast turnaround time. Based on application, the global general influenza diagnostics market is divided into hospitals, clinical laboratories, and other end-users such as military establishments and research institutes & universities.
Product Definition:
General Influenza Diagnostics is a term used to describe the various methods and techniques used to diagnose an influenza infection. The importance of General Influenza Diagnostics is that it allows healthcare providers to identify and treat patients who are infected with the influenza virus.
RIDT:
RIDT is a rapid diagnostic test that helps in the detection of viruses causing influenza. It also helps in differentiating between types of viruses such as avian (bird) flu, swine flu and human (avian) flu. RIDT is used along with other tests to help confirm an individual’s diagnosis for having thefluorosis. The test works by detecting antibodies created by the body in response to infection or disease.
Viral Culture:
Viral culture is a procedure used to grow viruses in labs for the study of various aspects such as pathology, virology, immunology and pathogenesis. It's also used as an important tool in the diagnosis of viral infections like influenza. The process involves infecting a susceptible host with virus and then observing the infection at different stages such as when it first takes place (viral inoculation) till completion (viral growth).
Application Insights:
The hospitals segment dominated the overall market in 2017. This can be attributed to the high usage of diagnostic tests for detecting influenza infection and a growing number of hospital admissions due to flu-related complications. According to WHO, during the 2014-2016 season, over 99 million people were treated in hospital outpatient departments worldwide. In addition, around 662 thousand deaths were reported due to pneumonia and influenza related causes globally during this same period.
Based on application, the global general influenza diagnostics market is segmented into clinical laboratories, hospitals and other end-user facilities such as emergency rooms or clinics. Hospitals accounted for a larger share owing to their central location that allows easy access by healthcare professionals for conducting diagnosis quickly resulting in early treatment of disease along with prevention measures being taken against future occurrences of similar diseases within an affected population group or community (epidemic).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure and high adoption rate of novel flu diagnostics tools are some factors responsible for its large share. Furthermore, the region is expected to maintain its dominance over the forecast period owing to continuous technological advancements in diagnostic methods and increasing demand for rapid & effective diagnosis from public as well as private sectors.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising target population base, improving healthcare facilities & infrastructure, and an increase in government initiatives pertaining towards disease control & prevention activities. Moreover, economic development coupled with improvement in living standards has led people from lower socio-economic groups who were previously unaffected by seasonal epidemics become candidates for virus infection leading source of infection thus creating a potential growth opportunity for these tests across this region.
Growth Factors:
- Increasing incidence of influenza and other respiratory infections
- Rising demand for rapid and accurate diagnosis
- Growing awareness about the benefits of early diagnosis and treatment
- Technological advancements in diagnostic methods
- Expansion of the global market for general influenza diagnostics
Scope Of The Report
Report Attributes
Report Details
Report Title
General Influenza Diagnostics Market Research Report
By Type
RIDT, Viral Culture, DFA, Serological Assays
By Application
Hospitals, Clinical Laboratories, Other End-User
By Companies
F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, DiaSorin, bioMérieux
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global General Influenza Diagnostics Market Report Segments:
The global General Influenza Diagnostics market is segmented on the basis of:
Types
RIDT, Viral Culture, DFA, Serological Assays
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinical Laboratories, Other End-User
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F. Hoffmann-La Roche
- Quidel Corporation
- Thermo Fisher Scientific
- Abbott Laboratories
- Becton, Dickinson, and Company
- DiaSorin
- bioMérieux
Highlights of The General Influenza Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- RIDT
- Viral Culture
- DFA
- Serological Assays
- By Application:
- Hospitals
- Clinical Laboratories
- Other End-User
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the General Influenza Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
General Influenza Diagnostics is a laboratory that provides diagnostic services for influenza viruses. The company offers tests to identify the type of influenza virus, as well as tests to determine if a person has been infected with the virus. General Influenza Diagnostics also provides information about the best ways to prevent and treat the flu.
Some of the key players operating in the general influenza diagnostics market are F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, DiaSorin, bioM©rieux.
The general influenza diagnostics market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 General Influenza Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 General Influenza Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 General Influenza Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the General Influenza Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global General Influenza Diagnostics Market Size & Forecast, 2018-2028
4.5.1 General Influenza Diagnostics Market Size and Y-o-Y Growth
4.5.2 General Influenza Diagnostics Market Absolute $ Opportunity
Chapter 5 Global General Influenza Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 General Influenza Diagnostics Market Size Forecast by Type
5.2.1 RIDT
5.2.2 Viral Culture
5.2.3 DFA
5.2.4 Serological Assays
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global General Influenza Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 General Influenza Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinical Laboratories
6.2.3 Other End-User
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global General Influenza Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 General Influenza Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America General Influenza Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America General Influenza Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America General Influenza Diagnostics Market Size Forecast by Type
9.6.1 RIDT
9.6.2 Viral Culture
9.6.3 DFA
9.6.4 Serological Assays
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America General Influenza Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinical Laboratories
9.10.3 Other End-User
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe General Influenza Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe General Influenza Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe General Influenza Diagnostics Market Size Forecast by Type
10.6.1 RIDT
10.6.2 Viral Culture
10.6.3 DFA
10.6.4 Serological Assays
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe General Influenza Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinical Laboratories
10.10.3 Other End-User
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific General Influenza Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific General Influenza Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific General Influenza Diagnostics Market Size Forecast by Type
11.6.1 RIDT
11.6.2 Viral Culture
11.6.3 DFA
11.6.4 Serological Assays
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific General Influenza Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinical Laboratories
11.10.3 Other End-User
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America General Influenza Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America General Influenza Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America General Influenza Diagnostics Market Size Forecast by Type
12.6.1 RIDT
12.6.2 Viral Culture
12.6.3 DFA
12.6.4 Serological Assays
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America General Influenza Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinical Laboratories
12.10.3 Other End-User
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) General Influenza Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) General Influenza Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) General Influenza Diagnostics Market Size Forecast by Type
13.6.1 RIDT
13.6.2 Viral Culture
13.6.3 DFA
13.6.4 Serological Assays
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) General Influenza Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinical Laboratories
13.10.3 Other End-User
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 General Influenza Diagnostics Market: Competitive Dashboard
14.2 Global General Influenza Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F. Hoffmann-La Roche
14.3.2 Quidel Corporation
14.3.3 Thermo Fisher Scientific
14.3.4 Abbott Laboratories
14.3.5 Becton, Dickinson, and Company
14.3.6 DiaSorin
14.3.7 bioMérieux
